Ivermectin, Oxfendazole, Levamisole, Praziquantel, Selenium & Cobalt
Treble ITape, for the treatment and control of Tapeworm and Internal Parasites in sheep.
Gastrointestinal Parasites
Haemonchus contortus* (Barber’s Pole), Ostertagia cirumcincta* ( Brown Stomach Worm), Trichostrongylus axei ( Black Scour Worm), Trichostrongylus colubriformis, Cooperia spp* , Oesophagostomum spp, Nematodirus fillicollis, Nematodirus spathiger, Strongloides papillosis, Oesophagastomum venulosum, Chabertia ovina, Trichuris ovis
Tapeworms - Heads and Segments Moniezia expansaLungworm - Dictyocaulus spp
Directions for use
Shake well before use
Active+ Treble iTape Oral is ready to use through standard drenching equipment. Dose the mob to heaviest animal in each group (ewes, wethers, rams, lambs). Do not underdose. Where there is a large variation in size within the group, dose rate should be based on the label directions for each weight range. Wash out drench gun before and after use, and check accuracy of drench guns regularly.
DOSE RATE: 1ml per 5kg bodyweight
| Bodyweight | Dose Rate | Doses per 10L |
| 16 – 20kg | 4mL | 2500 |
| 21 – 25kg | 5mL | 2000 |
| 26 – 30kg | 6mL | 1666 |
| 36 – 40kg | 8mL | 1250 |
| 46 – 50kg | 10mL | 1000 |
| 56 – 60kg | 12mL | 833 |
| 66 – 70kg | 14mL | 714 |
Do not use at the same time as any other selenised fertilizer, prill or product without consulting a veterinarian
Do not exceed the stated dose, or frequency.
Caution: In sheep, liver levels of copper may be quite variable. Consequently, there is always a risk of copper poisoning.
Doses of 3 or more times recommended dose can cause symptoms of levamisole toxicity, so estimate live weights carefully.
Fatal interactions may occur between levamisole and organophosphate dips.
Dehydrated animals may be more susceptible to toxicity.
MEAT: Animals producing meat or offal for human consumption must not be sold for slaughter during or within 21 days of the last treatment.
MILK: Milk intended for sale for human consumption must be discarded during treatment and for not less than 35 days following the last treatment
Registered pursuant to the ACVM Act I997, No. A11498